Validation of ICD-11 Chronic Pain Severity Specifiers for Children and Adolescents: An important step forward

The adoption of ICD-11 chronic pain severity specifiers marks an important evolution in pain classification[1]. By incorporating pain intensity, pain-related distress, and pain-related interference, this framework aligns with the biopsychosocial nature of chronic pain and provides a structured approach to characterizing the lived experience of pain. However, given that ICD-11 criteria were originally developed for adults[6], their validation in pediatric populations is critical to ensure clinical applicability and meaningful assessment.

The study by Rau et al. (2024) takes a significant first step in adapting and validating these severity specifiers for children and adolescents, an effort for which the authors should be commended. Here I highlight key implications of this study for the field of pediatric chronic pain: (1) the importance and necessity of validating pain severity specifiers in youth; (2) methodological considerations, including the need for temporal coherence and (3) diversity of sample characteristics for validation; and (4) next steps for refining chronic pain classification in pediatrics, including validation in less impaired populations.

The Value of a Multidimensional Pain Severity Framework

A major contribution of this study is its focus on pain-related distress and interference, which are often overlooked in clinical pain assessments. Historically, pain assessment tools have over-relied on intensity ratings, despite ample evidence that functional outcomes and emotional responses to pain play a crucial role in treatment planning and prognosis. By evaluating three key dimensions—pain intensity, distress, and interference—this study reinforces the multidimensional nature of pain severity in youth. The findings indicate that these dimensions are interrelated yet distinct, which supports their clinical relevance. As the authors highlight, the ICD-11 framework is a step toward a more comprehensive classification system that could facilitate comparisons across international samples and support standardized data collection for research and policy. However, the psychometric findings highlight an ongoing challenge: while these specifiers provide a quick and pragmatic way to characterize pain, their utility for clinical decision-making remains limited. The study finds modest predictive validity for treatment recommendations, suggesting that these items should not be used in isolation to guide therapeutic decisions. Rather, they should be embedded within a broader pain assessment battery that includes functional and psychological measures. Updated recommendations from the Core Outcomes in Pediatric Persistent Pain Workgroup provide guidance in measure selection for clinical trials that can also apply to clinical contexts for rigorous assessment[4].

The Need for Temporal Coherence in Validation

One important methodological limitation—which the authors acknowledge—is the timing mismatch between patient-reported outcomes and the pain severity specifier ratings used for validation. Pain-related distress and interference were correlated with measures collected two months prior to the clinical appointment, raising concerns about temporal coherence in assessing these constructs. Given that these specifiers consist of single-item numerical ratings, capturing their more proximal fluctuations is essential. Pain-related distress, in particular, may be more accurately validated using measures that specifically tap into pain-related emotions, such as pain catastrophizing[5] or pain-related fear[2], rather than broad measures of anxiety and depression. While general distress and pain-related distress are often correlated, they are not interchangeable constructs. This study highlights an important area for refinement, future research should aim to validate pain distress using measures that align more directly with this construct. Additionally, the seven-day recall period for the pain severity items—inherited from the ICD-11 adult framework—may not fully capture the dynamic nature of pediatric pain. Children’s pain experiences can fluctuate rapidly due to developmental, environmental, and contextual factors. Future studies should consider potentially both shorter and longer recall periods to improve accuracy and clinical relevance.

The Impact of Sample Characteristics on Generalizability

A notable feature of this study is the high level of impairment and pain persistence in the sample. With average pain intensity ratings above 7 and almost 60% of participants living with pain for more than three years, this represents a severely affected clinical cohort. Furthermore, 63% of patients were recommended for interdisciplinary pain treatment (IIPT), reinforcing their pain severity. While this highly impaired sample provides valuable insights, it also underscores the need for future validation in less impaired groups to ascertain if the same severity categories and cutoffs will be applicable.

Next steps

To enhance the applicability of these specifiers, validation studies should be conducted across diverse clinical settings including primary care (e.g., pediatricians, school health clinics), subspecialty clinics (e.g., gastroenterology, rheumatology, neurology), and diverse cultural and linguistic populations. Cross-validation will ensure that ICD-11 specifiers can be meaningfully applied across the full spectrum of pediatric pain conditions. Additionally, while the study tested the WHO-recommended severity categories (none, mild, moderate, severe), further research is needed to determine whether these cutoffs are appropriate for pediatric populations. Alternative approaches, such as function-based cutoffs (e.g., return to school, resumption of daily activities) or treatment-responsive thresholds (e.g., defining meaningful improvement based on response to therapy) may improve the clinical utility of ICD-11 specifiers in treatment planning and outcome evaluation. And lastly, given the dynamic nature of pediatric pain, the future of pain severity assessment may lie in digital tracking tools. Wearable sensors, mobile health (mHealth) apps, and digital pain diaries could offer real-time monitoring of pain distress and interference, improved ecological validity over single time-point recall measures, better insights into pain fluctuations[3] and treatment response.

In closing, Rau et al. provide a rigorous and much-needed validation of the ICD-11 chronic pain severity specifiers for pediatric patients, highlighting both their promise and limitations. Their findings reinforce the multidimensional nature of pain severity while underscoring the need for improved methodological approaches to enhance validity and generalizability. Moving forward, these specifiers should be integrated within broader pain assessment models, with further validation in diverse clinical populations. Future research should focus on optimizing pain-related distress measures, ensuring temporal coherence, and leveraging digital tools to enhance assessment accuracy. By refining these classification tools, we can advance personalized pain care and improve treatment pathways for youth with chronic pain.